Drug Profile
AGN 209323
Alternative Names: AGN-0001; AGN-001; AGN-209323; EHT-0001; EHT-001; EHT/AGN-0001Latest Information Update: 18 May 2020
Price :
$50
*
At a glance
- Originator Allergan; ExonHit Therapeutics
- Developer Bristol-Myers Squibb
- Class Analgesics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neuropathic pain